1.15 -0.11 (-8.73%)

50.85% Fall from 52W High

445.2K XNAS Volume

High vol.+gain this week

XNAS 24 Mar, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Opus Genetics Inc. is on 28 Mar 2025 for the purpose of Opus Genetics Inc Annual Report for 2024 See details


Board Meetings - Opus Genetics Inc.

The next board meeting for Opus Genetics Inc. is on 28 Mar 2025 for the purpose of Opus Genetics Inc Annual Report for 2024

Ex-date Purpose Notes
11 Jun 2025 Ocuphire Pharma Inc Annual General Meeting for 2025 -
09 May 2025 Ocuphire Pharma Inc First Quarter Earnings Results for 2025 -
28 Mar 2025 Opus Genetics Inc Annual Report for 2024 -
21 Mar 2025 Opus Genetics Inc Fourth Quarter Earnings Results for 2024 -
14 Mar 2025 Opus Genetics Inc Annual Report for 2024 -
14 Mar 2025 Opus Genetics Inc Fourth Quarter Earnings Results for 2024 -
07 Mar 2025 Opus Genetics Inc Annual Report for 2024 -
07 Mar 2025 Opus Genetics Inc Fourth Quarter Earnings Results for 2024 -
13 Nov 2024 Frontiers in Ocular Gene Therapy Research Conference -
13 Nov 2024 Ocuphire Pharma Inc Third Quarter Earnings Results for 2024 -
12 Nov 2024 Opus Genetics Inc Third Quarter Earnings Results for 2024 -
22 Oct 2024 Ocuphire Pharma, Inc. Investor Call Announcing the Acquisition of Opus Genetics, Inc. -
16 Aug 2024 Ocuphire Pharma Inc Second Quarter Earnings Results for 2024 -
15 Aug 2024 Ocuphire Pharma, Inc. will participateH.C. Wainwright 4th Annual Ophthalmology Virtual Conference -
14 Aug 2024 Canaccord Genuity 44th Annual Growth Conference -
13 Aug 2024 Ocuphire Pharma Inc Second Quarter Earnings Results for 2024 -
09 Aug 2024 Ocuphire Pharma Inc Second Quarter Earnings Results for 2024 -
11 Jun 2024 Ocuphire Pharma Inc Annual General Meeting for 2024 -
06 Jun 2024 Ocuphire Pharma Inc Annual General Meeting for 2024 -
15 May 2024 Ocuphire Pharma Inc First Quarter Earnings Results for 2024 -
10 May 2024 Ocuphire Pharma Inc First Quarter Earnings Results for 2024 -
08 May 2024 Aegis Capital Virtual Conference -
05 May 2024 Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting -
29 Mar 2024 Ocuphire Pharma Inc Annual Report for 2023 -
29 Mar 2024 Ocuphire Pharma Inc Fourth Quarter Earnings Results for 2023 -
08 Mar 2024 Ocuphire Pharma Inc Fourth Quarter Earnings Results for 2023 -
08 Mar 2024 Ocuphire Pharma Inc Annual Report for 2023 -
05 Dec 2023 Ocuphire Pharma Corporate Update Call -
13 Nov 2023 Ocuphire Pharma Inc Third Quarter Earnings Results for 2023 -
03 Nov 2023 Ocuphire Pharma Inc Third Quarter Earnings Results for 2023 -
11 Aug 2023 Ocuphire Pharma Inc Second Quarter Earnings Results for 2023 -
06 Jun 2023 Ocuphire Pharma Inc Annual General Meeting for 2023 -
15 May 2023 Ocuphire Pharma Inc First Quarter Earnings Results for 2023 -
30 Mar 2023 Ocuphire Pharma Inc Annual Report for 2022 -
30 Mar 2023 Ocuphire Pharma Inc Fourth Quarter Earnings Results for 2022 -
04 Nov 2022 Ocuphire Pharma Inc Third Quarter Earnings Results for 2022 -
12 Aug 2022 Ocuphire Pharma Inc Second Quarter Earnings Results for 2022 -
13 Jun 2022 Ocuphire Pharma Inc Annual General Meeting for 2022 -
13 May 2022 Ocuphire Pharma Inc First Quarter Earnings Results for 2022 -
24 Mar 2022 Ocuphire Pharma Inc Annual Report for 2021 -
24 Mar 2022 Ocuphire Pharma Inc Fourth Quarter Earnings Results for 2021 -
12 Nov 2021 Ocuphire Pharma Inc Third Quarter Earnings Results for 2021 -
12 Aug 2021 Ocuphire Pharma Inc Second Quarter Earnings Results for 2021 -
07 Jun 2021 Ocuphire Pharma Inc Annual General Meeting for 2020 -
07 May 2021 Ocuphire Pharma Inc First Quarter Earnings Results for 2021 -
11 Mar 2021 Ocuphire Pharma Inc Fourth Quarter Earnings Results for 2020 -
11 Mar 2021 Ocuphire Pharma Inc Annual Report for 2020 -
29 Oct 2020 Ocuphire Pharma Inc Third Quarter Earnings Results for 2020 -
14 Aug 2020 Ocuphire Pharma Inc Second Quarter Earnings Results for 2020 -
07 May 2020 Ocuphire Pharma Inc First Quarter Earnings Results for 2020 -
21 Feb 2020 Ocuphire Pharma Inc Fourth Quarter Earnings Results for 2019 -
21 Feb 2020 Ocuphire Pharma Inc Annual Report for 2019 -